2017-03-07,Alcobra Ltd. To Participate In Upcoming Healthcare Conferences
2017-03-01,INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
2017-03-01,Alcobra To Host Investor Forum And Webcast On March 28 In New York City
2017-02-17,Lifshitz & Miller LLP Files Class Action Lawsuit Against Alcobra, Ltd.
2017-02-15,Alcobra Announces Fourth-Quarter And Full-Year 2016 Financial Results And Provides Corporate Update
2017-02-08,Alcobra Ltd. To Release Fiscal 2016 Financial Results And Participate At The BIO CEO & Investor Conference In New York
2017-02-06,Alcobra Reports On Productive FDA Meeting For New Lead Product Candidate For ADHD
2017-02-02,Lifshitz & Miller Law Firm Announces Investigation Of Alcobra Ltd., Egalet Corporation, Sanderson Farms, Inc., Surgical Care Affiliates, Inc., State Street Corporation, Tenet Healthcare Corp., Vista Outdoor Inc. And Zagg Inc.
2017-01-31,IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Alcobra, Ltd., And Encourages Investors To Contact The Firm
2017-01-19,SHAREHOLDER ALERT: Lundin Law PC Announces An Investigation Of Alcobra, Ltd. And Encourages Investors With Losses To Contact The Firm
2017-01-19,SHAREHOLDER ALERT: Goldberg Law PC Announces An Investigation Of Alcobra, Ltd. And Advises Investors With Losses To Contact The Firm
2017-01-18,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of Alcobra Ltd.
2017-01-17,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Alcobra Ltd. (ADHD)
2017-01-17,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Alcobra Ltd. - ADHD
2017-01-17,Alcobra Shares Plummet as ADHD Drug Fails
2017-01-17,Alcobra Reports Phase 3 Clinical Trial Of MDX In Adults With ADHD Missed Primary Endpoint
2017-01-09,Alcobra Provides Update On Recent FDA Meeting And Path Forward For MDX Clinical Development Program
2016-12-14,Alcobra Updates On Recent FDA Meeting
2016-11-15,Alcobra Announces Third Quarter 2016 Financial Results And Provides Corporate Update
2016-11-15,Corbus Pharma Bear Thesis Is Alive and Well on Sclerosis Drug Data Skewed Positive
2016-11-07,Alcobra Ltd. To Participate In Upcoming Healthcare Conferences
2016-11-01,Alcobra Ltd. To Release Third Quarter Financial Results And Host Corporate Update Conference Call & Webcast On November 15
2016-10-07,Update From Alcobra On Recent FDA Communications
2016-09-30,Alcobra (ADHD) Stock Sliding, Downgraded After FDA Clinical Hold
2016-09-29,Alcobra (ADHD) Stock Tumbles on FDA Clinical Hold, Cantor Remains Bullish
2016-09-28,Alcobra Announces IND Clinical Hold Affecting The MDX Phase III MEASURE Study
2016-08-30,Alcobra Announces Second Quarter 2016 Financial Results And Provides Corporate Update
2016-08-15,Alcobra Ltd. To Release Second Quarter Financial Results And Host Corporate Update Conference Call & Webcast On Tuesday, August 30
2016-07-19,Alcobra Granted European Orphan Drug Designation For Metadoxine In Fragile X Syndrome
2016-07-05,Alcobra Ltd. To Present At The Cantor Fitzgerald 2nd Annual Healthcare Conference
2016-06-01,Alcobra Ltd. To Participate In Upcoming Investment Conferences
2016-05-20,7 Stocks Under $10 Making Big Moves Higher
2016-05-16,Alcobra Announces First Quarter 2016 Financial Results And Provides Corporate Update
2016-05-04,Alcobra Ltd. To Release First Quarter Financial Results And Host Corporate Update Conference Call & Webcast On May 16
2016-03-01,Alcobra Ltd. To Present At Upcoming Investment Conferences
2016-02-17,CORRECTING And REPLACING -- Alcobra Announces Fourth Quarter And Fiscal 2015 Financial Results And Provides Corporate Update
2016-02-17,Alcobra Announces Fourth Quarter And Fiscal 2015 Financial Results And Provides Corporate Update
2016-02-02,Alcobra Ltd. To Release Fourth Quarter And Fiscal Year 2015 Financial Results And Host Corporate Update Conference Call & Webcast On February 17
2016-01-28,Alcobra Ltd. To Present At Upcoming Investment Conferences
2016-01-11,RSI Alert: Alcobra (ADHD) Now Oversold
2015-12-18,Alcobra Enters Oversold Territory (ADHD)
2015-12-17,Alcobra Added To The NASDAQ Biotechnology Index
2015-11-24,Alcobra Ltd. To Participate In Piper Jaffray 27th Annual Healthcare Conference
2015-11-16,Alcobra Ltd. To Present At Upcoming Investment Conferences Company Will Host Corporate Update Conference Call & Webcast On November 17
2015-11-13,Alcobra Ltd. Prices Public Offering Of Ordinary Shares
2015-11-12,Alcobra Ltd. Announces Proposed Public Offering Of Ordinary Shares
2015-11-12,Alcobra Announces Third Quarter 2015 Financial Results And Provides Corporate Update
2015-11-05,Alcobra Ltd. To Release Third Quarter 2015 Financial Results And Host Corporate Update Conference Call & Webcast On November 17
2015-09-21,FDA Grants Fast Track Designation To Alcobra's MDX For Fragile X Syndrome
2015-08-13,Alcobra Announces Second Quarter 2015 Financial Results And Provides Corporate Update
2015-08-03,Alcobra Ltd. To Release Second Quarter 2015 Financial Results And Host Corporate Update Conference Call & Webcast On August 13
2015-07-13,Alcobra Announces Election Of Dr. Joao Siffert To Board Of Directors
2015-07-12,Breadth Is Key Over the Next Few Days
2015-06-24,Alcobra Placebo Beats Drug in Failed Genetic Disease Study
2015-06-24,Alcobra Announces Results From Phase 2 Clinical Trial Of MDX For Fragile X Syndrome
2015-06-23,Alcobra Ltd. To Present Results Of Phase II Fragile X Trial In A Conference Call & Webcast Presentation On Wednesday, June 24
2015-05-28,Alcobra Ltd. To Present At Two Conferences In June
2015-05-06,Alcobra Announces First Quarter 2015 Financial Results And Provides Corporate Update
2015-04-27,Alcobra Ltd. To Participate At Two Conferences In May
2015-04-16,Alcobra Ltd. To Release First Quarter 2015 Financial Results And Host Corporate Update Conference Call & Webcast On May 6
2015-04-06,Alcobra Ltd. To Present At Two CNS Focused Conferences In April
2015-03-10,Alcobra's MDX Meets Primary Endpoint In Phase II Safety And Tolerability Clinical Trial In Adolescents With ADHD
2015-03-03,Alcobra Ltd. To Present At 27th Annual ROTH Conference
2015-02-27,5 Stocks Poised for Big Breakouts: Xoom, Alcobra and More
2015-02-26,5 Stocks Under $10 to Trade for Breakouts: SouFun, Repros and More
2015-02-17,4 Biotech Stocks Under $10 to Trade for Breakouts: Sophiris, Atossa and More
2015-02-12,Alcobra Announces Fourth Quarter And Fiscal Year 2014 Financial Results And Provides Corporate Update
2015-02-02,Alcobra Ltd. To Release Fourth Quarter And Fiscal Year 2014 Financial Results And Host Corporate Update Conference Call & Webcast On February 12
2015-01-29,Alcobra Ltd. To Present At BIO CEO & Investor Conference
2015-01-14,Alcobra Ltd. Announces Closing Of Public Offering Of Ordinary Shares And Full Exercise Of Over-Allotment Option
2015-01-09,UPDATE - UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Notifies Investors Of Class Action Against Alcobra Ltd. And Its Board Of Directors And A Lead Plaintiff Deadline Of January 20, 2015 -- ADHD
2015-01-09,Alcobra Ltd. Prices Public Offering Of Ordinary Shares
2015-01-08,Alcobra Ltd. Announces Commencement Of Public Offering Of Ordinary Shares
2015-01-02,ADHD SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of Class Action Against Alcobra Ltd. And Its Board Of Directors And A Lead Plaintiff Deadline Of January 19, 2015 -- ADHD
2014-12-30,SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alcobra Ltd. To Contact Brower Piven Before The January 19, 2015 Lead Plaintiff Deadline In Class Action Lawsuit
2014-12-17,Alcobra Ltd. Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors
2014-12-08,Law Offices Of Marc S. Henzel Announces Securities Class Action Periods
2014-12-01,SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alcobra Ltd. To Contact Brower Piven Before The January 19, 2015 Lead Plaintiff Deadline In Class Action Lawsuit
2014-11-26,INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Alcobra Ltd. (ADHD) To Contact The Firm
2014-11-24,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Alcobra Ltd - ADHD
2014-11-24,Alcobra Ltd. To Present At Investor Conferences In December
2014-11-21,SHAREHOLDER ALERT: Investigation On Behalf Of Alcobra, Ltd. Investors Announced By Law Offices Of Howard G. Smith
2014-11-19,SHAREHOLDER ALERT: Class Action Lawsuit Against Alcobra, Ltd. Filed By Glancy Binkow & Goldberg LLP
2014-11-17,Alcobra Announces Third Quarter Financial Results And Provides Corporate Update
2014-11-06,Alcobra Ltd. To Release Third Quarter 2014 Financial Results And Host Corporate Update Conference Call And Webcast On Monday, November 17
2014-11-03,Alcobra Ltd. To Present At Investor Conferences In November
2014-10-31,SHAREHOLDER ALERT: The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Securities Laws Violations By The Board Of Directors Of Alcobra Ltd.
2014-10-27,Block & Leviton LLP Investigates Alcobra Ltd, Its Officers And Directors For Possible Violations Of The Federal Securities Laws
2014-10-23,Alcobra Applies Revisionist History to ADHD Drug Study Analysis
2014-10-23,Alcobra Announces Presentation Of New Data From Phase III Adult ADHD Study At AACAP Annual Meeting
2014-10-17,5 Stocks Under $10 Set to Soar
2014-10-07,It's True, Small-Cap Biotech Stocks Are Acting Badly These Days
2014-10-06,Why Alcobra (ADHD) Stock Hit a One-Year Low Today
2014-10-06,Alcobra ADHD Drug Fails Key Study Except When Patients Removed From Analysis
2014-10-06,Alcobra Announces Topline Results From Phase III Study Of MDX In Adult ADHD
2014-10-01,Oversold Conditions For Alcobra (ADHD)
2014-09-24,Why Alcobra Investors Are So Nervous About a Coming Drug Study
2014-09-19,Alcobra Announces Completion Of All Patient Visits In Phase III Clinical Trial Of MDX In Adult ADHD
2014-09-05,Alcobra Ltd. To Present At The Aegis Healthcare & Technology Conference
2014-09-02,Alcobra Announces Enrollment Of First Patient In Phase IIb Clinical Trial Of MDX In Adolescents With ADHD
2014-08-27,Why Alcobra (ADHD) Stock Is Declining Today
2014-08-26,Your September Biotech Back-to-School Calendar
2014-08-19,Alcobra Announces Enrollment Of First Patient In Phase IIb Clinical Trial Of MDX In Fragile X Syndrome
2014-08-11,Alcobra Announces Second Quarter Financial Results And Provides Corporate Update
2014-08-08,Alcobra Releases New Neuroimaging Data Supporting Pro-Cognitive Effects Of MDX
2014-08-06,Alcobra Ltd. To Provide Corporate Overview At The Canaccord Genuity 34th Annual Growth Conference
2014-08-01,Alcobra Ltd. To Release Second Quarter 2014 Results And Host Investor Conference Call And Webcast On Monday, August 11
2014-07-17,Alcobra Discusses New Market Research And Updates On Recent Corporate Events At Investor Forum In New York City
2014-07-14,Alcobra Completes Patient Recruitment In Phase III Clinical Trial Of MDX In Adult ADHD
2014-07-10,14 Insanely Important Biotech/Drug Trading Catalysts for the Rest of 2014
2014-07-07,Alcobra To Host Investor Forum And Webcast On July 15 In New York City
2014-07-07,3 Big-Volume Stocks to Trade for Breakouts
2014-07-03,5 Stocks Spiking on Unusual Volume
2014-06-17,Alcobra Ltd. To Provide Corporate Overview At The JMP Securities Healthcare Conference
2014-06-09,Alcobra To Present At The American Society Of Clinical Psychopharmacology Annual Meeting And The BIO International Convention
2014-05-27,Alcobra Ltd. To Provide Corporate Overview At The Jefferies 2014 Global Healthcare Conference
2014-05-23,Alcobra Ltd. To Present At The Gordon Research Conference On Fragile X And Autism-Related Disorders
2014-05-15,Alcobra Announces First Quarter Financial Results And Corporate Update
2014-05-12,Alcobra Ltd. Presents Evidence Of Novel Mechanism Of Action For Metadoxine Extended Release (MDX) In Cognitive Disorders At The Society Of Biological Psychiatry Annual Meeting
2014-05-08,Alcobra Announces FDA Clearance Of Protocol For Phase IIb Study Of Metadoxine Extended Release (MDX) In The Treatment Of Fragile X Syndrome
2014-05-08,Alcobra Ltd. To Provide Corporate Overview At Oppenheimer And BioMed Conferences
2014-05-07,Alcobra Ltd. To Release First Quarter 2014 Results And Host Investor Conference Call On Thursday, May 15, 2014
2014-05-05,Alcobra Ltd. Presents Positive Results From Phase IIb Study Of Metadoxine Extended Release (MDX) In Adults With Predominantly Inattentive ADHD At APA Annual Meeting
2014-05-01,Alcobra Issued New US Patent Covering Metadoxine Use For Cognitive Disorders
2014-04-24,Alcobra Ltd. To Present New Data For Metadoxine Extended Release (MDX) At Upcoming Meetings
2014-04-10,Alcobra Ltd. Submits Protocol To FDA For Phase IIb Clinical Study Of Metadoxine Extended Release (MDX) In The Treatment Of Fragile X Syndrome
2014-04-08,Relative Strength Alert For Alcobra
2014-03-26,Alcobra Announces Shares Uplisted To NASDAQ Global Market
2014-03-18,Alcobra Announces Enrollment Of First Patient In Phase 3 Clinical Trial For MDX In Adult ADHD
2014-03-06,Alcobra Announces FDA Clearance Of IND For Metadoxine Extended Release (MDX)
2014-02-24,Alcobra Ltd. To Discuss Biomarkers In Fragile X And Autism Trials At The Second Annual Autism Investment Conference
2014-02-19,Alcobra Appoints J.P. Morgan Banker Dr. Tomer Berkovitz As Chief Financial Officer
2014-02-13,Alcobra Announces Fourth Quarter And Fiscal Year End 2013 Financial Results And Corporate Update
2014-02-07,Alcobra Announces IND Submission For Extended Release Metadoxine To Treat Adults With ADHD
2014-01-31,Alcobra Ltd. To Provide Corporate Overview At 16th Annual BIO CEO & Investor Conference
2014-01-29,Alcobra Ltd. To Release Fourth Quarter 2013 Results And Host Investor Conference Call On Thursday, February 13, 2014
2014-01-27,Alcobra Announces New Biomarker Finding In A Follow-Up Fragile X Animal Study For MG01CI
2014-01-13,Alcobra Strengthens Management Team With Addition Of Industry Veteran David C. Baker As Chief Commercial Officer
2013-12-18,FDA Grants Orphan Drug Status To Metadoxine In Fragile X Syndrome
2013-12-16,Alcobra Ltd. Announces Highly Statistically Significant Positive Phase IIb Clinical Trial Results In Adults With Predominantly Inattentive Attention Deficit Hyperactivity Disorder
2013-12-16,5 Stocks Ready to Break Out
2013-12-02,Alcobra To Present At The 25th Annual Piper Jaffray Healthcare Conference
2013-11-22,Alcobra Ltd. Announces New Findings On Diminished Abuse Potential Of Its Proprietary Drug Candidate, MG01CI
2013-11-07,Alcobra Ltd. Reports Third Quarter 2013 Results
2013-11-05,Alcobra Successfully Completes Enrollment In Comparative Phase II Study Of Attention And Cognitive Function Benefits In Patients With PI-ADHD
2013-10-31,Alcobra Ltd. To Host A Third Quarter 2013 Conference Call On November 7th
2013-10-30,Alcobra Ltd. Announces Closing Of Approximately $38 Million Public Offering Of Ordinary Shares
2013-10-29,Alcobra Ltd. Announces Full Exercise Of Over-Allotment Option By Underwriters
2013-10-24,Alcobra Ltd. Prices Public Offering Of $33 Million Of Ordinary Shares
2013-10-23,Biotech Stock Bubble Debate in 14 Charts
2013-10-21,Alcobra Ltd. To Present At AACAP's 60th Annual Meeting On October 24th
2013-10-14,Alcobra Ltd. Announces New Findings On Novel Mechanism Of Action For Its Proprietary Drug, MG01CI, For Treatment Of Cognitive Dysfunctions
2013-10-02,Alcobra Ltd. Selects CNS Clinical Trials Expert Premier Research As CRO For Phase III Clinical Study Of MG01CI As A Treatment For Adults With ADHD
2013-09-25,Alcobra To Present Fragile X Study Results At 2013 FRAXA Investigators Meeting
2013-09-19,Alcobra Ltd. To Present At The Aegis Capital 2013 Annual Healthcare Conference On September 26th In Las Vegas
2013-09-10,Alcobra's Pre-Clinical Fragile X Study For MG01CI Shows Significant Positive Results
2013-09-03,Alcobra Ltd. To Present At The Stifel Nicolaus 2013 Annual Healthcare Conference On September 11th
2013-08-26,Alcobra Enrolls First Patient In Comparative Study Of Executive Function Benefits In Patients With PI-ADHD
2013-08-06,Alcobra Ltd. Reports Second Quarter 2013 Results
2013-07-30,Alcobra Ltd. To Host ADHD Seminar In New York City On August 6, 2013
2013-07-30,Alcobra Ltd. Appoints Dr. Jonathan Rubin As Chief Medical Officer
2013-07-24,Alcobra Ltd. To Provide Second Quarter 2013 Financials And Business Update On August 6th
2013-07-11,Alcobra Plans to Break ADHD Ranks
2013-06-24,Alcobra Ltd. Announces U.S. Patent Issuance
2013-06-03,Alcobra Ltd. To Ring The NASDAQ Stock Market Opening Bell On Thursday, June 6th
2013-05-28,Alcobra Ltd. Announces Closing Of Initial Public Offering
2013-05-28,Alcobra Ltd. To Present At Upcoming Investor Conferences
